• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Korea·Industrials·112610.KS
Share

CS Wind Corporation Stocks

₩ 40950Last Updated 26.10.2026

Issuer Rating

5/7
Performance

Favourable

Risk

Limited

Recommendation

Hold

Market Cap

₩ 1.38B

₩ 40950
Key Takeaways

Risk factor

Good trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Slightly undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

CS Wind Corporation, established in 2006 as Choong San Wind Corporation before adopting its current name in 2007, is a leading international manufacturer based in Cheonan, South Korea. The company specializes in the production and global distribution of wind power infrastructure, offering a comprehensive range of components such as onshore and offshore wind towers, critical transition pieces for marine windfarms, and essential internal tower elements like cables, platforms, ladders, and brackets. Beyond its core wind energy contributions, CS Wind also manufactures a diverse array of industrial plant equipment, including rectifiers, after washers, FLSH hoppers, cold and hot separators, propylene fractionators, H2S removal columns, strippers, LPG splitters, amine and naphtha absorbers, and rich amine surge drums. Additionally, their extensive product line features various metal fabrications such as aluminum and steel platforms, door frames, shipping fixtures, pipes for the oil and gas industry, transportation tools, steel parts, pressure vessels, reactors, heat exchangers, columns, storage tanks, and boilers. The company's market presence extends across numerous countries, notably Vietnam, China, Canada, the United Kingdom, Turkey, Taiwan, Malaysia, and Australia, among other international locations.

Company Valuation

Slightly undervalued
5/7

Based on key historical and expected multiples, the stock is slightly undervalued relative to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EB

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Somewhat favourable
5/7

The average target price of 112610.KS is 65744 and suggests 50.3% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation t

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

26.10.2026 22:15

Revolut has begun offering consumer loans in the U.K. What does this mean for the company?

26.10.2026 21:31

Tesla shares surged: Barclays advised buying them ahead of the merger with SpaceX

26.10.2026 21:09

"We Decided Not to Delay": What Analysts Are Saying About Anthropic's IPO Prospectus

26.10.2026 19:24

Highlights from Anthropic's prospectus—one of the most anticipated IPOs of the year: online

26.10.2026 19:13

Aardvark sinks 65% on data from halted trial of hunger drug; FDA to allow new tests

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026